Barclays Downgrades Qiagen to Equal-Weight, Announces $44 Price Target

Benzinga Newsdesk www.benzinga.com Negative 53.3%

Neg 53.3% Neu 0% Pos 0%

Barclays analyst Luke Sergott downgrades Qiagen (NYSE:QGEN) from Overweight to Equal-Weight and announces $44 price target.